Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Bone Diseases × saracatinib × Genitourinary × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1 Genitourinary 1 Breast 1

Conditions

Prostatic Neoplasms 3 Breast Neoplasms 1 Bone Neoplasms 1 Bone Diseases 1

Interventions

saracatinib 1 etelcalcetide hydrochloride 1 Zoledronic Acid 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00558272 2013-05-27

Study to Evaluate the Safety and Effects AZD0530 on Prostate and Breast Cancer Subjects With Metastatic Bone Disease

AstraZeneca

Phase 2 Completed

139 enrolled 23 charts

BreastGenitourinarySarcoma

Bone Diseases, Bone Neoplasms, Breast Neoplasms, Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡